[go: up one dir, main page]

AU2009225346B2 - Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease - Google Patents

Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease

Info

Publication number
AU2009225346B2
AU2009225346B2 AU2009225346A AU2009225346A AU2009225346B2 AU 2009225346 B2 AU2009225346 B2 AU 2009225346B2 AU 2009225346 A AU2009225346 A AU 2009225346A AU 2009225346 A AU2009225346 A AU 2009225346A AU 2009225346 B2 AU2009225346 B2 AU 2009225346B2
Authority
AU
Australia
Prior art keywords
hepatitis
virus
inhibitors
serine protease
sulfur compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009225346A
Other versions
AU2009225346A1 (en
Inventor
Ashok Arasappan
Frank Bennett
Stephane L. Bogen
Kevin X. Chen
Viyyoor M. Girijavallabhan
Siska Hendrata
Yuhua Huang
Yi-Tsung Liu
Raymond G. Lovey
Latha Nair
F. George Njoroge
Anil K. Saksena
Mousumi Sannigrahi
Francisco Velazquez
Srikanth Venkatraman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005222060A external-priority patent/AU2005222060A1/en
Application filed by Merck Sharp and Dohme LLC filed Critical Merck Sharp and Dohme LLC
Priority to AU2009225346A priority Critical patent/AU2009225346B2/en
Publication of AU2009225346A1 publication Critical patent/AU2009225346A1/en
Assigned to MERCK SHARP & DOHME CORP. reassignment MERCK SHARP & DOHME CORP. Alteration of Name(s) of Applicant(s) under S113 Assignors: SCHERING CORPORATION
Application granted granted Critical
Publication of AU2009225346B2 publication Critical patent/AU2009225346B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2009225346A 2004-02-27 2009-10-14 Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease Ceased AU2009225346B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2009225346A AU2009225346B2 (en) 2004-02-27 2009-10-14 Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54867004P 2004-02-27 2004-02-27
US60/548,670 2004-02-27
AU2005222060A AU2005222060A1 (en) 2004-02-27 2005-02-24 Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
AU2009225346A AU2009225346B2 (en) 2004-02-27 2009-10-14 Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2005222060A Division AU2005222060A1 (en) 2004-02-27 2005-02-24 Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease

Publications (2)

Publication Number Publication Date
AU2009225346A1 AU2009225346A1 (en) 2009-11-05
AU2009225346B2 true AU2009225346B2 (en) 2012-11-22

Family

ID=

Similar Documents

Publication Publication Date Title
IL177544A0 (en) Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
IL177545A0 (en) Compounds as inhibitors of hepatitis c virus ns3 serine protease
ZA200607053B (en) Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
ZA200907353B (en) Sulfur compounds as inhibitors of Hepatitis C Virus NS3 serine protease
ZA200607134B (en) Inhibitors of hepatitis C virus NS3 protease
IL176237A0 (en) Inhibitors of hepatitis c virus ns3/ns4a serine protease
IL174459A0 (en) Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
TWI367211B (en) Hcv ns-3 serine protease inhibitors
IL177628A0 (en) Novel ketoamides with cyclic p4s as inhibitors of ns3 serine protease of hepatitis c virus
IL195512A0 (en) Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
IL162815A0 (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
EP1590442A3 (en) Macrocyclic hepatitis c serine protease inhibitors
AU2009225346B2 (en) Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease
HK1097528A (en) Compounds as inhibitors of hepatitis c virus ns3 serine protease
HK1103408A (en) Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease
HK1097262A (en) Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
HK1095838A (en) Inhibitors of hepatitis c virus ns3 protease
HK1134306A (en) Sulfur compounds as inhiibitors of hepatitis c virus ns3 serine protease
HK1097261A (en) Inhibitors of hepatitis c virus ns3/ns4a serine protease
HK1090930A (en) Depeptidized inhibitors of hepatitis c virus ns3 protease
HK1086844A (en) Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
HK1088339A (en) Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
HK1096657A (en) Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus